Stress and the Impact of Personalized Medicine

Charles F. Gillespie, Elisabeth B. Binder, Paul E. Holtzheimer, Charles Nemeroff

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

Original languageEnglish
Title of host publicationIntegrative Neuroscience and Personalized Medicine
PublisherOxford University Press
ISBN (Print)9780199863495, 9780195393804
DOIs
StatePublished - Jan 1 2011

Fingerprint

Precision Medicine
Anxiety Disorders
Mood Disorders
Epigenomics
Anxiety
Depression
Therapeutics

Keywords

  • Abuse
  • Anxiety
  • Brain imaging
  • Depression
  • Genes
  • Ghypothalamic-pituitary-adrenal axis
  • Neuroendocrine
  • SNPs
  • Stress
  • Stressors

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Gillespie, C. F., Binder, E. B., Holtzheimer, P. E., & Nemeroff, C. (2011). Stress and the Impact of Personalized Medicine. In Integrative Neuroscience and Personalized Medicine Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195393804.003.0005

Stress and the Impact of Personalized Medicine. / Gillespie, Charles F.; Binder, Elisabeth B.; Holtzheimer, Paul E.; Nemeroff, Charles.

Integrative Neuroscience and Personalized Medicine. Oxford University Press, 2011.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gillespie, CF, Binder, EB, Holtzheimer, PE & Nemeroff, C 2011, Stress and the Impact of Personalized Medicine. in Integrative Neuroscience and Personalized Medicine. Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195393804.003.0005
Gillespie CF, Binder EB, Holtzheimer PE, Nemeroff C. Stress and the Impact of Personalized Medicine. In Integrative Neuroscience and Personalized Medicine. Oxford University Press. 2011 https://doi.org/10.1093/acprof:oso/9780195393804.003.0005
Gillespie, Charles F. ; Binder, Elisabeth B. ; Holtzheimer, Paul E. ; Nemeroff, Charles. / Stress and the Impact of Personalized Medicine. Integrative Neuroscience and Personalized Medicine. Oxford University Press, 2011.
@inbook{70457045a5664a9b8076ad4919635b9e,
title = "Stress and the Impact of Personalized Medicine",
abstract = "This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.",
keywords = "Abuse, Anxiety, Brain imaging, Depression, Genes, Ghypothalamic-pituitary-adrenal axis, Neuroendocrine, SNPs, Stress, Stressors",
author = "Gillespie, {Charles F.} and Binder, {Elisabeth B.} and Holtzheimer, {Paul E.} and Charles Nemeroff",
year = "2011",
month = "1",
day = "1",
doi = "10.1093/acprof:oso/9780195393804.003.0005",
language = "English",
isbn = "9780199863495",
booktitle = "Integrative Neuroscience and Personalized Medicine",
publisher = "Oxford University Press",

}

TY - CHAP

T1 - Stress and the Impact of Personalized Medicine

AU - Gillespie, Charles F.

AU - Binder, Elisabeth B.

AU - Holtzheimer, Paul E.

AU - Nemeroff, Charles

PY - 2011/1/1

Y1 - 2011/1/1

N2 - This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

AB - This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

KW - Abuse

KW - Anxiety

KW - Brain imaging

KW - Depression

KW - Genes

KW - Ghypothalamic-pituitary-adrenal axis

KW - Neuroendocrine

KW - SNPs

KW - Stress

KW - Stressors

UR - http://www.scopus.com/inward/record.url?scp=84920752641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920752641&partnerID=8YFLogxK

U2 - 10.1093/acprof:oso/9780195393804.003.0005

DO - 10.1093/acprof:oso/9780195393804.003.0005

M3 - Chapter

SN - 9780199863495

SN - 9780195393804

BT - Integrative Neuroscience and Personalized Medicine

PB - Oxford University Press

ER -